Reklaim Ltd. Strengthens Balance Sheet with 18% Debt Reduction
Reduction highlights Reklaim's disciplined financial management
Separate from the debt reduction, Reklaim has completed a non-brokered private placement of convertible debenture units (the "Debenture Units") totalling
The Debentures accrue interest at a rate of 12.0% per annum, are payable semi-annually, and mature in 2027. The Company reserves the right to repay the Debentures early.
Each warrant entitles the holder to purchase one common share (each a "Share") at an exercise price of
No commissions or fees are payable by the Company in connection with the Offering. The Offering remains subject to final approval by the TSXV, and all securities issued under the Offering are subject to a hold period of four months plus one day, in accordance with applicable securities laws.
Additional Information:
The Company has also agreed to issue 16,380 common shares (the "Settlement Shares") at a price of
About Reklaim Ltd.
Reklaim provides compliant, consumer-permissioned data to Fortune 500 brands, platforms, and data companies, empowering individuals to take control of their personal information. By visiting Reklaim, users can confirm their identity and uncover data collected and sold without their explicit consent. Through a Reklaim account, consumers can choose to monetize their data or safeguard it using Reklaim's suite of privacy tools. For more information, visit Reklaim's investor page.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements:
This news release contains forward-looking statements and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will," "may," "should," "anticipate," "expects," and similar expressions.
All statements other than those of historical fact included in this release—including, but not limited to, statements regarding the TSXV's final approval of the Offering, the intended use of proceeds, and the closing of the Debt Settlement—are forward-looking statements involving risks and uncertainties. There can be no assurance that such statements will be accurate, and actual results may differ materially. Investors are cautioned not to place undue reliance on any forward-looking information.
View original content to download multimedia:https://www.prnewswire.com/news-releases/reklaim-ltd-strengthens-balance-sheet-with-18-debt-reduction-302375477.html
SOURCE Reklaim Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
- Additional Information on the Ehrmann Family Increasing Its Equity Stake in Artprice by Artmarket as Part of Artprice's "AI-First" Transformation
- Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Signs New FF Par Agreement with a Leading U.S. Robotics Distributor and Provides Details on FF EAI Robotics “Built in USA�
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share